Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341896 · ClinicalTrials.gov registry record
Healthcare Utilization in Obese Caregiver Living Donors
A clinical trial of Obesity and Utilization, Health Care, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 784
- Enrollment target
- 1
- Study location
NCT04341896: Completed study of Obesity and Utilization, Health Care, sponsored by University of Alabama at Birmingham.
NCT04341896 is a study of Obesity and Utilization, Health Care that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 784 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04341896, a study of Obesity and Utilization, Health Care, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 784 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to estimate risk of post-donation healthcare use attributable to informal caregiving among obese living donors. Improving our understanding of the relationship between caregiving, donation, and healthcare use will allow us to improve living donor informed consent and post-donation care, particularly among older donors and those of minority race/ethnicity.
Primary Outcome
Proportion self-reporting at least one visit to the emergency department since donation/previous questionnaire
Conditions Studied
Interventions
- OTHER Caregivers
- OTHER Non-caregivers
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 784 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2024-12-01 |
What the finished NCT04341896 record still lists
NCT04341896 is an observational study that tracks outcomes without assigning an intervention. The registered 784 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Caregivers is the first listed.
NCT04341896 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04341896 about?
NCT04341896 is a clinical study titled "Healthcare Utilization in Obese Caregiver Living Donors". The goal of this study is to estimate risk of post-donation healthcare use attributable to informal caregiving among obese living donors. Improving our understanding of the relationship between caregiving, donation, and healthcare use will allow us to improve living donor informed consent and post-d...
What is the current status of trial NCT04341896?
This trial is currently completed. The enrollment target is 784 participants. The study started on 2020-07-01. Estimated completion is 2024-12-01.
What conditions does trial NCT04341896 study?
This clinical trial studies the following conditions: Obesity, Utilization, Health Care.
What interventions are being tested in trial NCT04341896?
The interventions under investigation include: Caregivers (OTHER), Non-caregivers (OTHER).
Who is sponsoring clinical trial NCT04341896?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04341896 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04341896's enrollment target sits among peer trials
784 95th of 1053 higher than 959 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06118723 · 784 participants
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- NCT06498128 · 785 participants
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
- NCT06575192 · 783 participants · Phase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
- NCT07276724 · 786 participants · Phase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI